Cancer rates may be on the rise among adults under 50, but Orlando Health has launched a new home program to help younger breast cancer patients manage treatment.

Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled ...